Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET500 for Penile Skin Sensation
NCT04247230Phase 1Completed
- Sponsor
- Futura Medical plc
- Start
- Sep 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of tetracaine in premature ejaculation (PE) (5 arms), sponsored by Futura Medical plc. Primary endpoints: Onset of action of different doses of a newly formulated tetracaine spray PET500 at 2 months and Duration of action of different doses of a newly formulated tetracaine spray PET500 at 2 months. Started Sep 2008; status: completed.
02
Drugs
tetracaine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT04247230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04247230.